Across TCGA pan-cancer cohorts, NUP62CL Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated NUP62CL data layer compared with 23 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher NUP62CL Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NUP62CL expression acts as an unfavorable survival marker.

HNSC and LUAD are the cancer types where NUP62CL Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.081	0.768	<.001	48	view →
LUAD	OS	Median	All	0.223	0.835	<.001	30	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: NUP62CL tumor-vs-normal RNA expression · all NUP62CL data types